SVG Sprites

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles

TAKE ACTION

Whether it’s a sore throat, diabetes or asthma or cancer, we all deserve affordable prescription medicines to feel better when we’re sick. It’s time to stop drug corporations from putting their profits ahead of our families and our health. Together, we can end big Pharma’s price-gouging, and rewrite the rules so everyone can afford the medicines they need to care for themselves and their families.

Our Principles

No matter where people live, what they look like or what’s in their wallets, at some point everyone is going to get sick and need prescription medicines. Whether it’s a sore throat, high blood pressure or cancer, everyone needs affordable medicine to lead healthy lives.

But today, drug corporations and their powerful Pharma lobbyists are standing in the way of our health and economic security. By jacking up prices to boost profits, they are forcing people to make stark choices – like choosing between medicine and other necessities, or going without treatment, or going into debt or watching loved ones suffer without the drugs they need to get better.

It doesn’t have to be this way. Together, we can change the system to make sure everyone gets access to medicines they can afford. We are a coalition that has come together to fight for transformative, bold reforms through legislative, legal and executive actions at the state and federal level based on these four principles:

GOVERNMENT RESPONSIBILITY

It is our government’s responsibility to guarantee that everyone in the United States, no matter where they live, what they look like or how much money they have, can afford the medicines they need to stay healthy and take care of their families. We oppose policies that put medicine out of reach for Americans or that deny or delay access to medicine for people in other countries.

AFFORDABLE ACCESS

Drug corporations and their lobbyists have rigged the rules of the pharmaceutical industry in order to drive up profits, putting medicines out of reach for millions of people. Their price gouging makes health and economic disparities even worse by putting the greatest pressure on the people who can least afford to bear the brunt of high prices. We must topple the barriers that systematically deny people access to medicines so that no one is left behind.

MAKING THE SYSTEM FAIR

We must curb drug corporations’ power to extract profits at the expense of people’s health by harnessing the government’s power to improve patients’ lives. This requires a range of concrete steps that re-write the rules to rein in drug corporations’ monopoly power to price gouge; that requires the drug industry to negotiate fair prices with government; and that holds corporations accountable for practices that directly and indirectly keep prices unjustifiably high.

PUTTING PUBLIC GOOD AHEAD OF CORPORATE PROFIT

We as taxpayers help foot the bill for a substantial amount of drug research, development and innovation, for drug purchasing through Medicare, Medicaid, and the Veterans Administration and for marketing, legal and patent protections for drug corporations. We must ensure government funding and incentives prioritize medical breakthroughs that most serve the public good rather than those that primarily extend monopolies and increase corporate profits. Everyone wants proven treatments and life-saving innovations, but prescription drugs are useless to people who can’t afford them. We must change the system to make sure everyone can benefit from our shared public investment in new drug research and development by ensuring that medicines are affordable and accessible to everyone.

Press

Press Releases 10.29.2020

New Report: Big Pharma Lobbying & Political Spending Match Senator Collins’ RX Votes

Lower Drug Prices Now released a new report highlighting how drug corporations’ spending on lobbying and elections match up with Senator Susan Collins’ votes on health care and prescription drug pricing. The new report, Connecting the Dots on Pharma Lobbying, Political Donations and Senator Collins’ Votes on Drug Pricing and Access, shows that while Senator Collins claims to be independent from the Trump Administration and the drug industry, her votes tell a different story.

Press Releases 10.29.2020

White House’s vaccine coverage plan fails to lower cost for Americans

Donald Trump is once again hoping that a last-minute PR stunt is going to disguise his failure to stop Big Pharma price gouging. Let’s be clear: vaccines and treatments for COVID are not free–Americans have already paid more than $12 billion in tax dollars to develop and manufacture them. Thanks to Trump’s refusal to rein in Big Pharma’s monopoly power to set prices, Medicare, Medicaid and private insurance corporations will be required to pay Big Pharma whatever price the corporations set for these drugs. That means taxpayers will get stuck paying twice as costs are shifted into higher premiums and increased taxes.

Press Releases 10.28.2020

New findings of Sackler family greed highlight Trump’s failed leadership

The Oversight Committee’s findings that the Sackler family continued to push opioids into the market even after a settlement with the DOJ in 2007 inspire further outrage over the Trump Administration’s legal settlements that fail to hold Big Pharma executives accountable for their greed. The Sackler family knowingly peddled a dangerous drug that has cost the lives of more than 750,000 Americans to date, and created years of needless suffering for millions more. These families deserve justice, not more of the same for their neighbors and communities.

Coalition Members